Beyfortus, a new shot for RSV, was 90% effective at preventing hospitalizations in children, new data shows.

The CDC panel’s recommendation moves the U.S. closer to making the respiratory syncytial virus shots from Pfizer and GSK available to seniors.

Respiratory syncytial virus (RSV) circulation is showing signs of return to pre-pandemic seasonality in the U.S. after two years of irregular onsets and peaks, the Centers for Disease Control and ...

CDC warns frenzy of respiratory viruses could continue to spread for MONTHS - as three-in-one $170 test can tell whether you've got Covid, RSV or flu ...

On Sept. 8, CDC data shows the nation’s RSV positivity rate (based on antigen tests) was around 8 percent. By Oct. 15, the positivity rate jumped to more than 15 percent.

Visit the U.S. CDC’s page for more information on how to protect yourself and your loved ones from the flu, COVID-19, and RSV Copy the Story Link Comments are not available on this story.

The CDC confirmed 33,041 infections during the week ending on December 17, a 26 percent week-over-week drop. Cases of RSV continued to fall too, dropping to 3,554.

Ritchey cited early signs of respiratory syncytial virus, or RSV, starting to increase this season as expected in Florida, which is called out at the top of this week's report. Behind the CDC's ...

Respiratory syncytial virus – better known by the acronym RSV – is rising in some southeastern U.S. states, the Centers for Disease Control and Prevention warned Tuesday, signaling the virus ...

The CDC panel’s recommendation moves the U.S. closer to making the respiratory syncytial virus shots from Pfizer and GSK available to seniors.